Attention Deficit/Hyperactivity Disorder (ADHD)
Showing 1 - 25 of >10,000
ADHD Trial in Taipei county (Aerobic exercise, Video-watching)
Recruiting
- Attention Deficit Hyperactivity Disorder
- Aerobic exercise
- Video-watching
-
Taipei county, TaiwanNeurophysiology and Cognition in Children and Young Adults Lab,
Nov 8, 2023
Attention-deficit Hyperactivity Disorder Trial in Tel Aviv (The efficacy of Equine Assisted Occupational Therapy, for children
Recruiting
- Attention-deficit Hyperactivity Disorder
- The efficacy of Equine Assisted Occupational Therapy, for children with Attention Deficit Hyperactivity Disorder (ADHD) on cognitive-emotional aspects, daily function and participation
-
Tel Aviv, IsraelTel Aviv University
May 21, 2023
Attention Deficit Hyperactivity Disorder (ADHD)
Completed
- ADHD
-
Orange, California
- +1 more
Jan 25, 2023
ADHD Trial (FDA approved medications for ADHD plus Quantitative EEG Neurofeedback, FDA approved medications for ADHD)
Not yet recruiting
- ADHD
- FDA approved medications for ADHD plus Quantitative EEG Neurofeedback
- FDA approved medications for ADHD
- (no location specified)
Nov 23, 2022
ADHD Trial in Boston (MRI)
Active, not recruiting
- Attention Deficit Hyperactivity Disorder
- MRI
-
Boston, MassachusettsMassachusetts General Hospital
Sep 22, 2022
ADHD Trial in Buffalo (Mobile behavioral parent training (mBPT) and prompts)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Mobile behavioral parent training (mBPT) and prompts
-
Buffalo, New YorkCenter for Children and Families of Western New York
Aug 28, 2023
ADHD Trial run by the National Human Genome Research Institute (NHGRI) (Floreo Virtual Reality application, Floreo Virtual
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Floreo Virtual Reality application
- Floreo Virtual Reality application - non-adaptive
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
ADHD Trial in New York (Cognitive-Behavioral Therapy Targeting Executive Dysfunction in College Students with ADHD)
Recruiting
- ADHD
- Cognitive-Behavioral Therapy Targeting Executive Dysfunction in College Students with ADHD
-
New York, New YorkCity College of New York
Oct 24, 2022
ADHD Trial in New York (Guanfacine, Lisdexamfetamine)
Terminated
- Attention Deficit Hyperactivity Disorder
-
New York, New YorkNew York State Psychiatric Institute
Jan 18, 2023
ADHD Trial in Hong Kong (fNIRS Neurofeedback-VR Training, Computerized Cognitive Training)
Recruiting
- ADHD
- fNIRS Neurofeedback-VR Training
- Computerized Cognitive Training
-
Hong Kong, Hong KongThe University of Hong Kong
Jun 12, 2023
ADHD Trial (Brief assessment protocol, Comprehensive assessment protocol)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Brief assessment protocol
- Comprehensive assessment protocol
- (no location specified)
Oct 18, 2022
Healthcare Resources and Costs of Attention Deficit
Completed
- Attention Deficit Hyperactivity Disorder (ADHD)
- No intervention
-
London, United KingdomIQVIA Ltd
Jul 11, 2022
ADHD, Healthy Trial in Geneva (Neurofeedback)
Recruiting
- ADHD
- Healthy
- Neurofeedback
-
Geneva, SwitzerlandTRE Unit (Trouble de la Régulation Emotionnelle) Department of p
Oct 13, 2022
ADHD, ADHD, ADHD - Combined Type Trial (CTx-1301 -Dexmethylphenidate 18.75mg, CTx-1301 -Dexmethylphenidate 25mg, CTx-1301
Not yet recruiting
- ADHD
- +5 more
- CTx-1301 -Dexmethylphenidate 18.75mg
- +3 more
- (no location specified)
Nov 1, 2022
ADHD Trial in Omaha (methylphenidate)
Completed
- Attention Deficit Hyperactivity Disorder
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Sep 16, 2022
Attention Deficit/Hyperactivity Disorder Trial in Paris (Self-hypnosis application, Questionnaires)
Not yet recruiting
- Attention Deficit/Hyperactivity Disorder
- Self-hypnosis application
- Questionnaires
-
Paris, FranceHôpital Necker-Enfants Malades
Feb 13, 2023
Attention Deficit/Hyperactivity Disorder Trial in New York (Centanafadine Hydrochloride)
Recruiting
- Attention Deficit/Hyperactivity Disorder
- Centanafadine Hydrochloride
-
New York, New YorkFor additional information regarding sites, contact 844-687-8522
Aug 31, 2022
ADHD Trial (Zentiva®, Placebo)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Zentiva®
- Placebo
- (no location specified)
Jan 9, 2023
Attention Deficit Disorder, Attention Deficit Disorder With Hyperactivity Trial in Charlestown (2 mA transcranial direct current
Recruiting
- Attention Deficit Disorder
- Attention Deficit Disorder With Hyperactivity
- 2 mA transcranial direct current stimulation (tDCS)
- +2 more
-
Charlestown, MassachusettsMassachusetts General Hospital
Jul 21, 2022
Attention Deficit/Hyperactivity Disorder Combined Type, ADHD Predominantly Inattentive Type, ADHD Predominantly Hyperactivity
Recruiting
- Attention Deficit/Hyperactivity Disorder Combined Type
- +3 more
- Methylphenidate- Ritalin IR (Immediate Release)
-
Ramat-Gan, IsraelADHD Medical Clinic, Child and Adolescent Psychiatry Unit, Sheba
May 16, 2022
Disruptive Mood Dysregulation Disorder, ADHD, Normal Physiology Trial run by the National Institute of Mental Health (NIMH)
Withdrawn
- Disruptive Mood Dysregulation Disorder
- +2 more
- Affective Posner fMRI frustration induction task
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 8, 2023
ADHD Trial in Durham (Real-Time functional Magnetic Resonance Imaging Feedback (RTFF))
Suspended
- ADHD
- Real-Time functional Magnetic Resonance Imaging Feedback (RTFF)
-
Durham, North CarolinaDuke ADHD Program
May 26, 2022
Attention Deficit Disorder With Hyperactivity (ADHD) Trial in Philadelphia (Transcranial Magnetic Stimulation (TMS), Sham
Completed
- Attention Deficit Disorder With Hyperactivity (ADHD)
- Transcranial Magnetic Stimulation (TMS)
- Sham Transcranial Magnetic Stimulation (Sham TMS)
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 3, 2022
Drug Use Study With Intuniv® in European Countries
Active, not recruiting
- Attention Deficit Hyperactivity Disorder (ADHD)
- No Intervention
-
Munich, Bavaria, GermanyReal World Insights EMEA IQVIA Commercial GmbH & Co. OHG
May 12, 2023
Attention-deficit Hyperactivity Trial in Reykjavik (Cognitive behavioral therapy for ADHD)
Active, not recruiting
- Attention-deficit Hyperactivity
- Cognitive behavioral therapy for ADHD
-
Reykjavik, Sæmundargata 2, IcelandUniversity of Iceland
Mar 17, 2022